<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03306706</url>
  </required_header>
  <id_info>
    <org_study_id>RRC/2017/1702</org_study_id>
    <secondary_id>HS21108 (B2017:106)</secondary_id>
    <nct_id>NCT03306706</nct_id>
  </id_info>
  <brief_title>Effect of Peas in Muffins on Blood Glucose and Appetite Control</brief_title>
  <acronym>PEA3</acronym>
  <official_title>A Randomized, Controlled, Cross-over Trial Examining the Effect of Peas in Muffins on Post-prandial Glycaemic Response and Satiety in Healthy Adults.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Boniface General Hospital Research Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agriculture and Agri-Food Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Boniface General Hospital Research Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is part of a group of studies whose overall goal is to accurately define the
      physiochemical and structural effects of pea varieties and relate these to blood glucose
      attenuation and appetite related sensations in healthy human volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized, controlled, cross-over study designed to examine the postprandial glycaemic
      response and appetite related sensations to peas in muffins will be conducted at the I.H.
      Asper Clinical Research Institute in Winnipeg, Manitoba. Eligible participants who have
      provided consent will be asked to attend 4 clinic visits in a fasted state. Participants will
      be given muffins containing peas at 2 visits and muffins without peas at 2 visits. At each
      visit participants will provide 7 venous blood samples via indwelling catheter, 7 capillary
      blood samples via finger poke, 2 urine samples, 5 questionnaires about their appetite and a
      questionnaire about the acceptability of the products. At the end of each visit, participants
      will eat pizza ad libitum, and the amount of pizza consumed will be measured to determine if
      the peas influenced the amount of calories consumed at lunch. Participants will record their
      food/beverage intake for the rest of the day. Each visit will last approximately 3h and be
      separated by 3-14 days.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 7, 2017</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>randomized, controlled, cross-over</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-prandial glucose response</measure>
    <time_frame>120 min</time_frame>
    <description>iAUC glucose</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-prandial insulin</measure>
    <time_frame>120 min</time_frame>
    <description>iAUC insulin</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Appetite ratings</measure>
    <time_frame>120 min</time_frame>
    <description>AUC for hunger, fullness, desire to eat and prospective consumption using visual analog scales</description>
  </secondary_outcome>
  <other_outcome>
    <measure>calorie intake</measure>
    <time_frame>16 hours</time_frame>
    <description>Number of calories consumed post-intervention until bedtime</description>
  </other_outcome>
  <other_outcome>
    <measure>Metabolomics</measure>
    <time_frame>120 min</time_frame>
    <description>Metabolite profile in plasma and urine</description>
  </other_outcome>
  <other_outcome>
    <measure>Acceptability of test products</measure>
    <time_frame>15 min</time_frame>
    <description>Rating of color, aroma, flavor, texture and frequency of eating</description>
  </other_outcome>
  <other_outcome>
    <measure>Gastrointestinal side effects</measure>
    <time_frame>24h</time_frame>
    <description>Incidence and duration of GI side effects</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Post-prandial Glycaemic Response</condition>
  <condition>Satiety</condition>
  <arm_group>
    <arm_group_label>whole yellow pea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 muffins containing 25g available carbohydrate from whole yellow peas. Intervention: Whole pea muffins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>split yellow pea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 muffins containing 25g available carbohydrate from split yellow peas. Intervention: Split pea muffins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>wheat-PPGR</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2 muffins containing 25g available carbohydrate from wheat flour. Intervention: Wheat muffins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>wheat-satiety</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2 muffins containing wheat flour to match the calories in the whole and split pea muffins.
Intervention: Wheat muffins</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whole pea muffins</intervention_name>
    <description>2 muffins containing whole peas</description>
    <arm_group_label>whole yellow pea</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Split pea muffins</intervention_name>
    <description>2 muffins containing split peas</description>
    <arm_group_label>split yellow pea</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Wheat muffins</intervention_name>
    <description>2 muffins containing wheat</description>
    <arm_group_label>wheat-PPGR</arm_group_label>
    <arm_group_label>wheat-satiety</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Generally healthy male or female, between the age of 18-40 years;

          2. Body mass index (BMI) 18.5-30.0 kg/m2;

          3. Habitually consume breakfast, lunch and dinner in the morning, mid-day and evening,
             respectively.

          4. Willing to provide informed consent;

          5. Willing/able to comply with the requirements of the study.

        Exclusion Criteria:

          1. Pregnant or lactating;

          2. Medical history of diabetes mellitus, fasting blood glucose ≥6.1 mmol/L, HbA1c ≥6.0%,
             or use of insulin or oral medication to control blood sugar;

          3. Medical history of cardiovascular disease;

          4. Systolic blood pressure &gt;140 mmHg or diastolic blood pressure &gt;90 mmHg;

          5. Fasting plasma total cholesterol &gt;7.8 mmol/L;

          6. Fasting plasma HDL &lt;0.9 mmol/L;

          7. Fasting plasma LDL &gt;5.0 mmol/L;

          8. Fasting plasma triglycerides &gt;2.3 mmol/L;

          9. Major surgery within the last 3 months;

         10. Medical history of inflammatory disease (ie. Systemic lupus erythematosis, rheumatoid
             arthritis, psoriasis) or use of any corticosteroid medications within 3 months;

         11. Medical history of liver disease or liver dysfunction (defined as plasma AST or ALT
             ≥1.5 times the upper limit of normal (ULN));

         12. Medical history of kidney disease or kidney dysfunction (defined as blood urea
             nitrogen and creatinine ≥ 1.8 times the ULN));

         13. Presence of a gastrointestinal disorder, daily use of any stomach acid-lowering
             medications or laxatives (including fibre supplements) within the past month or
             antibiotic use within the past 6 weeks;

         14. Active treatment for any type of cancer within 1 year prior to study start;

         15. Shift worker (a system of employment where an individual's normal hours of work are in
             part, outside the period of normal working day; 6am and 8pm);

         16. Smoking, use of tobacco or a nicotine replacement product (within the last 3 months);

         17. Allergies to peas;

         18. Aversion or unwillingness to eat study foods;

         19. Consuming &gt;4 servings of pulses per week;

         20. Use of any prescription or non-prescription drug, herbal or nutritional supplement
             known to affect glycaemia or appetite;

         21. Participation in another clinical trial, current or in the past 4 weeks;

         22. Unstable body weight (defined as &gt;5% change in 3 months) or actively participating in
             a weight loss program.

         23. Physical Activity Level &gt;1.8.

         24. Restraint score &gt;13 (factor 1) on the Three Factor Eating Questionnaire.

         25. Other medical, psychiatric, or behavioral factors that in the judgment of the
             principal Investigator may interfere with study participation or the ability to follow
             the intervention protocol;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heather Blewett, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Agriculture and Agri-Food Canada</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heather Blewett, PhD</last_name>
    <phone>2042372954</phone>
    <email>hblewett@sbrc.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>I.H. Asper Clinical Research Institute</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R2H2A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Blewett, Ph.D</last_name>
      <phone>204-237-2954</phone>
      <email>hblewett@sbrc.ca</email>
    </contact>
    <contact_backup>
      <last_name>Jay Petkau</last_name>
      <email>jpetkau@sbrc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Dan Ramdath, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sora Ludwig, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michel Aliani, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Public Health Agency of Canada and the Canadian Institute for Health Information. Obesity in Canada: A joint report from the Public Health Agency of Canada and the Canadian institute for health information. Government of Canada; 2011.</citation>
  </reference>
  <reference>
    <citation>Public Health Authority of Canada. Diabetes in Canada: Facts and figures from a public health perspective. 2011</citation>
  </reference>
  <reference>
    <citation>Sievenpiper JL, Kendall CW, Esfahani A, Wong JM, Carleton AJ, Jiang HY, Bazinet RP, Vidgen E, Jenkins DJ. Effect of non-oil-seed pulses on glycaemic control: a systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes. Diabetologia. 2009 Aug;52(8):1479-95. doi: 10.1007/s00125-009-1395-7. Epub 2009 Jun 13. Review.</citation>
    <PMID>19526214</PMID>
  </reference>
  <reference>
    <citation>Hamberg O, Rumessen JJ, Gudmand-Høyer E. Blood glucose response to pea fiber: comparisons with sugar beet fiber and wheat bran. Am J Clin Nutr. 1989 Aug;50(2):324-8.</citation>
    <PMID>2547300</PMID>
  </reference>
  <reference>
    <citation>Marinangeli CP, Jones PJ. Chronic intake of fractionated yellow pea flour reduces postprandial energy expenditure and carbohydrate oxidation. J Med Food. 2011 Dec;14(12):1654-62. doi: 10.1089/jmf.2010.0255.</citation>
    <PMID>22145774</PMID>
  </reference>
  <reference>
    <citation>Smith CE, Mollard RC, Luhovyy BL, Anderson GH. The effect of yellow pea protein and fibre on short-term food intake, subjective appetite and glycaemic response in healthy young men. Br J Nutr. 2012 Aug;108 Suppl 1:S74-80. doi: 10.1017/S0007114512000700.</citation>
    <PMID>22916818</PMID>
  </reference>
  <reference>
    <citation>Jenkins DJ, Thorne MJ, Camelon K, Jenkins A, Rao AV, Taylor RH, Thompson LU, Kalmusky J, Reichert R, Francis T. Effect of processing on digestibility and the blood glucose response: a study of lentils. Am J Clin Nutr. 1982 Dec;36(6):1093-101.</citation>
    <PMID>6293296</PMID>
  </reference>
  <reference>
    <citation>Li H, Song F, Xing J, Tsao R, Liu Z, Liu S. Screening and structural characterization of alpha-glucosidase inhibitors from hawthorn leaf flavonoids extract by ultrafiltration LC-DAD-MS(n) and SORI-CID FTICR MS. J Am Soc Mass Spectrom. 2009 Aug;20(8):1496-503. doi: 10.1016/j.jasms.2009.04.003. Epub 2009 Apr 14.</citation>
    <PMID>19443236</PMID>
  </reference>
  <reference>
    <citation>Habtemariam S. A-glucosidase inhibitory activity of kaempferol-3-O-rutinoside. Nat Prod Commun. 2011 Feb;6(2):201-3.</citation>
    <PMID>21425674</PMID>
  </reference>
  <reference>
    <citation>Blundell J, de Graaf C, Hulshof T, Jebb S, Livingstone B, Lluch A, Mela D, Salah S, Schuring E, van der Knaap H, Westerterp M. Appetite control: methodological aspects of the evaluation of foods. Obes Rev. 2010 Mar;11(3):251-70. doi: 10.1111/j.1467-789X.2010.00714.x. Epub 2010 Jan 29. Review.</citation>
    <PMID>20122136</PMID>
  </reference>
  <reference>
    <citation>European Food Safety Authority. Guidance on the scientific requirements for health claims related to appetite ratings, weight management, and blood glucose concentrations. EFSA Journal. 2012;10(3):2604.</citation>
  </reference>
  <reference>
    <citation>Health Canada. Draft guidance document: Satiety health claims on food [Internet].; 2012. Available from: http://www.hc-sc.gc.ca/fn-an/consult/satiety-satiete/document-consultation-eng.php</citation>
  </reference>
  <reference>
    <citation>Ames N, Blewett H, Storsley J, Thandapilly SJ, Zahradka P, Taylor C. A double-blind randomised controlled trial testing the effect of a barley product containing varying amounts and types of fibre on the postprandial glucose response of healthy volunteers. Br J Nutr. 2015 May 14;113(9):1373-83. doi: 10.1017/S0007114515000367. Epub 2015 Apr 8.</citation>
    <PMID>25850814</PMID>
  </reference>
  <reference>
    <citation>Johansson G, Westerterp KR. Assessment of the physical activity level with two questions: validation with doubly labeled water. Int J Obes (Lond). 2008 Jun;32(6):1031-3. doi: 10.1038/ijo.2008.42. Epub 2008 Apr 8.</citation>
    <PMID>18392036</PMID>
  </reference>
  <reference>
    <citation>Rabiee A, Magruder JT, Grant C, Salas-Carrillo R, Gillette A, DuBois J, Shannon RP, Andersen DK, Elahi D. Accuracy and reliability of the Nova StatStrip® glucose meter for real-time blood glucose determinations during glucose clamp studies. J Diabetes Sci Technol. 2010 Sep 1;4(5):1195-201.</citation>
    <PMID>20920440</PMID>
  </reference>
  <reference>
    <citation>Mollard RC, Luhovyy BL, Smith C, Anderson GH. Acute effects of pea protein and hull fibre alone and combined on blood glucose, appetite, and food intake in healthy young men--a randomized crossover trial. Appl Physiol Nutr Metab. 2014 Dec;39(12):1360-5. doi: 10.1139/apnm-2014-0170. Epub 2014 Aug 2.</citation>
    <PMID>25302637</PMID>
  </reference>
  <reference>
    <citation>Akhavan T, Anderson GH. Effects of glucose-to-fructose ratios in solutions on subjective satiety, food intake, and satiety hormones in young men. Am J Clin Nutr. 2007 Nov;86(5):1354-63.</citation>
    <PMID>17991646</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 2, 2017</study_first_submitted>
  <study_first_submitted_qc>October 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2017</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Boniface General Hospital Research Centre</investigator_affiliation>
    <investigator_full_name>Dr. Heather Blewett</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>blood sugar</keyword>
  <keyword>insulin</keyword>
  <keyword>appetite</keyword>
  <keyword>peas</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All IPD that underlie results in a publication.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

